Physician profile
Ryan Faught
NPI 1871913269
$3,914.61
in general payments reported to CMS, 2019-2025
7 companies · $2,883 in 2025
The $2,883 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $851 · 2023: $168 · 2024: $13.32 · 2025: $2,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,499 · Food and Beverage: $815 · Education: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,498.70 |
| Food and Beverage | $815.09 |
| Education | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,309.80 | 2022-2025 | |
| Medtronic, INC. | $808.96 | 2025 | Cd Horizon Spinal System |
| Davol INC. | $528.97 | 2022-2025 | Phasix Mesh |
| Tela Bio, INC. | $86.34 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $81.48 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tactile Systems Technology INC | $65.82 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Musculoskeletal Transplant Foundation INC. | $33.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Faught listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.